
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
Case History: 70-year-old male with left-sided weakness and history of myocardial infarction four years prior.
Case History: 70-year-old male presents with left-sided weakness for 15 days and history of myocardial infarction four years prior.


